Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min

Link to article at PubMed

Am J Health Syst Pharm. 2021 Jun 9:zxab245. doi: 10.1093/ajhp/zxab245. Online ahead of print.


In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

PMID:34107027 | DOI:10.1093/ajhp/zxab245

Leave a Reply

Your email address will not be published.